TAK Annual Operating Profit
$1.48 B
-$2.61 B-63.78%
31 March 2024
Summary:
As of January 23, 2025, TAK annual operaing income is $1.48 billion, with the most recent change of -$2.61 billion (-63.78%) on March 31, 2024. During the last 3 years, it has fallen by -$2.27 billion (-60.49%). TAK annual operating profit is now -68.79% below its all-time high of $4.75 billion, reached on March 31, 2022.TAK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Quarterly Operating Profit
$1.84 B
+$775.29 M+72.66%
01 September 2024
Summary:
As of January 23, 2025, TAK quarterly operating income is $1.84 billion, with the most recent change of +$775.29 million (+72.66%) on September 1, 2024. Over the past year, it has increased by +$775.29 million (+72.66%). TAK quarterly operating profit is now -34.37% below its all-time high of $2.81 billion, reached on December 31, 2008.TAK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK TTM Operating Profit
$3.15 B
+$2.18 B+226.55%
01 September 2024
Summary:
As of January 23, 2025, TAK TTM operating income is $3.15 billion, with the most recent change of +$2.18 billion (+226.55%) on September 1, 2024. Over the past year, it has increased by +$2.18 billion (+226.55%). TAK TTM operating profit is now -38.99% below its all-time high of $5.16 billion, reached on December 31, 2008.TAK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TAK Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -63.8% | +72.7% | +226.6% |
| 3 y3 years | -60.5% | +59.1% | -23.6% |
| 5 y5 years | -14.5% | +231.7% | -20.0% |
TAK Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -68.8% | at low | at high | +545.3% | -35.8% | +226.6% |
| 5 y | 5-year | -68.8% | at low | -18.9% | +545.3% | -38.1% | +375.6% |
| alltime | all time | -68.8% | +225.5% | -34.4% | +152.4% | -39.0% | +328.3% |
Takeda Pharmaceutical Company Limited Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.84 B(+72.7%) | $3.15 B(+226.5%) |
| June 2024 | - | $1.07 B(+63.6%) | $963.96 M(-14.4%) |
| Mar 2024 | $1.48 B(-63.8%) | $652.28 M(-257.7%) | $1.13 B(-31.0%) |
| Dec 2023 | - | -$413.69 M(+21.1%) | $1.63 B(-47.2%) |
| Sept 2023 | - | -$341.59 M(-127.8%) | $3.09 B(-26.2%) |
| June 2023 | - | $1.23 B(+6.1%) | $4.19 B(+1.6%) |
| Mar 2023 | $4.10 B(-13.8%) | $1.16 B(+11.1%) | $4.12 B(+11.9%) |
| Dec 2022 | - | $1.04 B(+37.9%) | $3.68 B(+0.5%) |
| Sept 2022 | - | $756.01 M(-34.9%) | $3.66 B(-3.4%) |
| June 2022 | - | $1.16 B(+61.5%) | $3.79 B(-22.6%) |
| Mar 2022 | $4.75 B(+26.6%) | $719.44 M(-29.8%) | $4.90 B(+3.5%) |
| Dec 2021 | - | $1.02 B(+15.8%) | $4.74 B(-6.8%) |
| Sept 2021 | - | $885.15 M(-61.0%) | $5.08 B(+9.2%) |
| June 2021 | - | $2.27 B(+308.8%) | $4.65 B(+18.2%) |
| Mar 2021 | $3.76 B(+59.2%) | $555.42 M(-59.5%) | $3.94 B(-12.9%) |
| Dec 2020 | - | $1.37 B(+201.1%) | $4.52 B(+24.1%) |
| Sept 2020 | - | $455.13 M(-70.7%) | $3.64 B(-3.7%) |
| June 2020 | - | $1.55 B(+36.3%) | $3.78 B(+43.3%) |
| Mar 2020 | $2.36 B(+36.0%) | $1.14 B(+131.7%) | $2.64 B(+298.7%) |
| Dec 2019 | - | $492.11 M(-17.4%) | $661.81 M(-43.3%) |
| Sept 2019 | - | $595.43 M(+44.9%) | $1.17 B(-4.9%) |
| June 2019 | - | $410.95 M(-149.1%) | $1.23 B(-28.8%) |
| Mar 2019 | $1.73 B(+2.8%) | -$836.68 M(-183.9%) | $1.72 B(+31.4%) |
| Dec 2018 | - | $997.55 M(+52.1%) | $1.31 B(+20.0%) |
| Sept 2018 | - | $655.71 M(-27.7%) | $1.09 B(+38.0%) |
| June 2018 | - | $906.49 M(-172.6%) | $791.67 M(-51.7%) |
| Mar 2018 | $1.69 B(+86.0%) | -$1.25 B(-260.3%) | $1.64 B(-10.8%) |
| Dec 2017 | - | $778.64 M(+119.3%) | $1.84 B(+17.3%) |
| Sept 2017 | - | $354.99 M(-79.8%) | $1.57 B(+20.4%) |
| June 2017 | - | $1.75 B(-267.2%) | $1.30 B(+35.2%) |
| Mar 2017 | $907.09 M(-16.8%) | -$1.05 B(-306.9%) | $963.07 M(-43.2%) |
| Dec 2016 | - | $507.24 M(+467.8%) | $1.69 B(+2.3%) |
| Sept 2016 | - | $89.33 M(-93.7%) | $1.66 B(-19.8%) |
| June 2016 | - | $1.42 B(-545.1%) | $2.07 B(+95.2%) |
| Mar 2016 | $1.09 B | -$318.10 M(-167.8%) | $1.06 B(-176.7%) |
| Dec 2015 | - | $469.49 M(-5.8%) | -$1.38 B(+22.2%) |
| Sept 2015 | - | $498.36 M(+22.0%) | -$1.13 B(+1.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2015 | - | $408.54 M(-114.8%) | -$1.12 B(+23.8%) |
| Mar 2015 | -$1.18 B(-185.0%) | -$2.76 B(-482.6%) | -$901.85 M(-160.5%) |
| Dec 2014 | - | $720.15 M(+41.2%) | $1.49 B(+3.8%) |
| Sept 2014 | - | $509.99 M(-18.2%) | $1.43 B(-1.6%) |
| June 2014 | - | $623.45 M(-271.3%) | $1.46 B(+3.1%) |
| Mar 2014 | $1.39 B(+76.8%) | -$364.01 M(-154.7%) | $1.41 B(+66.9%) |
| Dec 2013 | - | $665.03 M(+24.8%) | $847.19 M(+20.9%) |
| Sept 2013 | - | $533.05 M(-8.0%) | $700.59 M(-6.9%) |
| June 2013 | - | $579.46 M(-162.3%) | $752.66 M(-21.1%) |
| Mar 2013 | $786.44 M(-76.6%) | -$930.35 M(-279.5%) | $953.73 M(-49.4%) |
| Dec 2012 | - | $518.44 M(-11.4%) | $1.88 B(-8.7%) |
| Sept 2012 | - | $585.12 M(-25.0%) | $2.06 B(+52.3%) |
| June 2012 | - | $780.53 M(>+9900.0%) | $1.36 B(-58.7%) |
| Mar 2012 | $3.36 B(-21.2%) | $101.00 K(-100.0%) | $3.28 B(-1474.8%) |
| Dec 2011 | - | $697.46 M(-667.2%) | -$238.52 M(-114.1%) |
| Sept 2011 | - | -$122.97 M(-104.5%) | $1.69 B(-61.3%) |
| June 2011 | - | $2.70 B(-176.9%) | $4.37 B(+7.9%) |
| Mar 2011 | $4.26 B(-5.9%) | -$3.52 B(-233.8%) | $4.05 B(-8.8%) |
| Dec 2010 | - | $2.63 B(+2.9%) | $4.44 B(+3.0%) |
| Sept 2010 | - | $2.56 B(+7.2%) | $4.31 B(+0.6%) |
| June 2010 | - | $2.39 B(-176.3%) | $4.29 B(-2.4%) |
| Mar 2010 | $4.53 B(+46.9%) | -$3.13 B(-225.1%) | $4.40 B(+1.2%) |
| Dec 2009 | - | $2.50 B(-1.3%) | $4.34 B(-6.6%) |
| Sept 2009 | - | $2.53 B(+1.6%) | $4.65 B(+4.0%) |
| June 2009 | - | $2.49 B(-178.4%) | $4.47 B(+125.9%) |
| Mar 2009 | $3.08 B(-17.0%) | -$3.18 B(-213.3%) | $1.98 B(-61.6%) |
| Dec 2008 | - | $2.81 B(+19.3%) | $5.16 B(+119.3%) |
| Sept 2008 | - | $2.35 B | $2.35 B |
| Mar 2008 | $3.71 B(-5.3%) | - | - |
| Mar 2007 | $3.92 B(+10.1%) | - | - |
| Mar 2006 | $3.56 B(-0.8%) | - | - |
| Mar 2005 | $3.59 B(+8.9%) | - | - |
| Mar 2004 | $3.30 B(+29.2%) | - | - |
| Mar 2003 | $2.55 B(+13.3%) | - | - |
| Mar 2002 | $2.25 B(+9.9%) | - | - |
| Mar 2001 | $2.05 B(+32.5%) | - | - |
| Mar 2000 | $1.55 B | - | - |
FAQ
- What is Takeda Pharmaceutical Company Limited annual operaing income?
- What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited quarterly operating income?
- What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?
- What is Takeda Pharmaceutical Company Limited TTM operating income?
- What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?
- What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?
What is Takeda Pharmaceutical Company Limited annual operaing income?
The current annual operating profit of TAK is $1.48 B
What is the all time high annual operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high annual operaing income is $4.75 B
What is Takeda Pharmaceutical Company Limited annual operating profit year-on-year change?
Over the past year, TAK annual operaing income has changed by -$2.61 B (-63.78%)
What is Takeda Pharmaceutical Company Limited quarterly operating income?
The current quarterly operating profit of TAK is $1.84 B
What is the all time high quarterly operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high quarterly operating income is $2.81 B
What is Takeda Pharmaceutical Company Limited quarterly operating profit year-on-year change?
Over the past year, TAK quarterly operating income has changed by +$775.29 M (+72.66%)
What is Takeda Pharmaceutical Company Limited TTM operating income?
The current TTM operating profit of TAK is $3.15 B
What is the all time high TTM operating profit for Takeda Pharmaceutical Company Limited?
Takeda Pharmaceutical Company Limited all-time high TTM operating income is $5.16 B
What is Takeda Pharmaceutical Company Limited TTM operating profit year-on-year change?
Over the past year, TAK TTM operating income has changed by +$2.18 B (+226.55%)